WST

WST Total Current Liabilities

$640.50MQuarterly · USD

Period ending:

WST FY Current LiabilitiesUSD
WST FY Current Liabilities1985-12-31: $16.30M1986-12-31: $42.90M1987-12-31: $44.70M1988-12-31: $43.50M1989-12-31: $47.00M1990-12-31: $64.70M1991-12-31: $70.90M1992-12-31: $60.90M1993-12-31: $46.80M1994-12-31: $86.30M1995-12-31: $61.80M1996-12-31: $65.60M1997-12-31: $58.00M1998-12-31: $104.20M1999-12-31: $104.00M2000-12-31: $79.30M2001-12-31: $75.30M2002-12-31: $87.70M2003-12-31: $118.90M2004-12-31: $116.50M2005-12-31: $124.80M2006-12-31: $156.90M2007-12-31: $182.90M2008-12-31: $159.10M2009-12-31: $171.10M2010-12-31: $169.70M2011-12-31: $243.20M2012-12-31: $261.80M2013-12-31: $236.90M2014-12-31: $252.50M2015-12-31: $314.30M2016-12-31: $241.00M2017-12-31: $279.50M2018-12-31: $283.70M2019-12-31: $341.60M2020-12-31: $503.40M2021-12-31: $594.10M2022-12-31: $519.00M2023-12-31: $671.80M2024-12-31: $550.40M2025-12-31: $654.90M$671.80M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WST total current liabilities history

Liabilities due within one year. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

West Pharmaceutical Services Total Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Current Liabilities (USD)
654,900,000
550,400,000
671,800,000
519,000,000
594,100,000
503,400,000
341,600,000
283,700,000
279,500,000
241,000,000
314,300,000
252,500,000
236,900,000
261,800,000
243,200,000
169,700,000
171,100,000
159,100,000
182,900,000
156,900,000
124,800,000
116,500,000
118,900,000
87,700,000
75,300,000
79,300,000
104,000,000
104,200,000
58,000,000
65,600,000
61,800,000
86,300,000
46,800,000
60,900,000
70,900,000
64,700,000
47,000,000
43,500,000
44,700,000
42,900,000
16,300,000

Compare total current liabilities

All WST financial metrics · WST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.